# Study to Investigate the Potential Pharmacological Effect of Oral Palmitoylethanolamide (PEA) Therapy in the Management of Low Back Pain (Neuropathic Pain)

> **NCT06694337** · NA · COMPLETED · sponsor: **Liaquat University of Medical & Health Sciences** · enrollment: 120 (actual)

## Conditions studied

- Low Back Pain

## Interventions

- **DIETARY_SUPPLEMENT:** 300 mg Palmitoylethanolamide (PEA) Phytosome®
- **DIETARY_SUPPLEMENT:** 450 mg Palmitoylethanolamide (PEA) Phytosome®
- **OTHER:** Control group

## Key facts

- **NCT ID:** NCT06694337
- **Lead sponsor:** Liaquat University of Medical & Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-28
- **Primary completion:** 2025-06-15
- **Final completion:** 2025-06-23
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06694337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06694337, "Study to Investigate the Potential Pharmacological Effect of Oral Palmitoylethanolamide (PEA) Therapy in the Management of Low Back Pain (Neuropathic Pain)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06694337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*